Skip to main content
. 2020 Oct;10(10):1984–1993. doi: 10.21037/qims-20-724

Table 2. Association between STAS and CT characteristics.

Characteristics Center I Center II
Nodules (n=462)   STAS status P value Nodules (n=116) STAS status P value
Positive (n=90) Negative (n=372) Positive (n=28) Negative (n=88)
Maximum diameter (mm) 20.00 (12.70, 30.20) 18.23 (11.59, 28.12) 24.53 (18.99, 37.51) <0.001 23.40 (16.60, 37.63) 37.78 (20.78, 49.23) 21.98 (15.13, 33.46) 0.002
Maximum area (mm2) 223.69 (89.67, 474.77) 172.04 (75.68, 426.30) 385.02 (222.47, 719.88) <0.001 302.295 (150.30, 781.53) 727.80 (284.07, 1,239.99) 251.83 (130.20, 626.61) 0.001
Area of the solid component (mm2) 114.08 (10.25, 384.46) 68.50 (0.00, 297.72) 336.88 (193.56, 674.67) <0.001 254.91 (52.97, 705.17) 585.88 (220.75, 1,160.43) 181.40 (49.70, 523.56) 0.001
Ratio of solid component (%) 58.97±42.88 85.17±30.04 52.64±43.15 <0.001 69.89±37.20 79.67±32.25 60.77±38.28 0.014
Nodule type, n (%) <0.001 0.096
   GGN 102 (22.1) 3 (3.3) 99 (26.6) 11 (9.5) 0 (0.0) 11 (12.5)
   Part-solid 141 (30.5) 17 (18.9) 124 (33.3) 41 (35.3) 9 (32.1) 32 (36.4)
   Solid 219 (47.4) 70 (77.8) 149 (40.1) 64 (55.2) 19 (67.9) 45 (51.1)
Pleural thickening, n (%) 0.002 0.186
   Present 287 (62.1) 69 (76.7) 218 (58.6) 84 (72.4) 23 (82.1) 61 (69.3)
   Absent 175 (37.9) 21 (23.3) 154 (41.4) 32 (27.6) 5 (17.9) 27 (30.7)
Pleural retraction, n (%) 0.001 0.142
   Present 275 (59.5) 67 (74.4) 208 (55.9) 78 (67.2) 22 (78.6) 56 (63.6)
   Absent 187 (40.5) 23 (25.6) 164 (44.1) 38 (32.8) 6 (21.4) 32 (36.4)
Mediastinal lymph node enlargement, n (%) 0.002 0.350
   Present 54 (11.7) 19 (21.1) 35 (9.4) 22 (19.0) 7 (25.0) 15 (17.0)
   Absent 408 (88.3) 71 (78.9) 337 (90.6) 94 (81.0) 21 (75.0) 73 (83.0)
Hilar lymphatic enlargement, n (%) 0.058 0.277
   Absent 51 (11.0) 15 (16.7) 36 (9.7) 21 (18.1) 7 (25.0) 14 (15.9)
   Present 411 (89.0) 75 (83.3) 336 (90.3) 95 (81.9) 21 (75.0) 74 (84.1)
Vascular cluster sign, n (%) <0.001 0.162
   Present 161 (34.8) 46 (51.1) 115 (30.9) 45 (38.8) 14 (50.0) 31 (35.2)
   Absent 301 (65.2) 44 (48.9) 257 (69.1) 71 (61.2) 14 (50.0) 57 (64.8)
Lobulation, n (%) <0.001 0.274
   Present 205 (44.4) 55 (61.1) 150 (40.3) 60 (51.7) 17 (60.7) 43 (48.9)
   Absent 257 (55.6) 35 (38.9) 222 (59.7) 56 (48.3) 11 (39.3) 45 (51.1)
Specula, n (%) <0.001 0.590
   Present 234 (50.3) 62 (68.9) 172 (46.2) 57 (49.1) 15 (53.6) 42 (47.7)
   Absent 228 (49.4) 28 (31.1) 200 (53.8) 59 (50.9) 13 (46.4) 46 (52.3)
Air bronchogram, n (%) 0.912 0.446
   Present 93 (20.1) 23 (25.6) 70 (18.8) 27 (23.3) 8 (28.6) 19 (21.6)
   Absent 369 (79.9) 67 (74.4) 302 (81.2) 89 (76.7) 20 (71.4) 69 (78.4)
Satellite lesions, n (%) 0.988 0.501
   Present 46 (10.0) 9 (10.0) 37 (9.9) 20 (17.2) 6 (21.4) 14 (15.9)
   Absent 416 (90.0) 81 (90.0) 335 (90.1) 96 (82.8) 22 (78.6) 74 (84.1)
Vacuolar sign, n (%) 0.437 0.706
   Present 99 (21.4) 22 (24.4) 77 (20.7) 26 (22.4) 7 (25.0) 19 (21.6)
   Absent 363 (78.6) 68 (75.6) 295 (79.3) 90 (77.6) 21 (75.0) 69 (78.4)
Void sign, n (%) 0.513 0.806
   Present 29 (6.3) 7 (7.8) 22 (5.9) 15 (12.9) 4 (14.3) 11 (12.5)
   Absent 433 (93.7) 83 (92.2) 350 (94.1) 101 (87.1) 24 (85.7) 77 (87.5)
Pleural effusion, n (%) 0.383 0.011
   Present 14 (3.0) 4 (4.4) 10 (2.7) 2 (1.7) 2 (7.1) 0 (0.0)
   Absent 448 (97.0) 86 (95.6) 362 (97.3) 114 (98.3) 26 (92.9) 88 (100.0)
Distribution within the lobe, n (%) 0.334 0.321
   Center 91 (19.7) 69 (76.7) 302 (81.2) 98 (84.5) 22 (78.6) 76 (86.4)
   Peripheral 371 (80.3) 21 (23.3) 70 (18.8) 18 (15.5) 6 (21.4) 12 (13.6)
Nodule location, n (%) 0.415 0.239
   LUL 116 (25.1) 27 (30.0) 89 (23.9) 29 (25.0) 11 (39.3) 18 (20.5)
   LLL 65 (14.1) 16 (17.8) 49 (13.2) 19 (16.4) 3 (10.7) 16 (18.2)
   RUL 164 (35.5) 26 (28.9) 138 (37.1) 43 (37.1) 7 (25.0) 36 (40.9)
   RML 33 (7.1) 5 (5.6) 28 (7.5) 6 (5.2) 2 (7.1) 4 (4.5)
   RLL 84 (18.2) 16 (17.8) 68 (18.3) 19 (16.4) 5 (17.9) 14 (15.9)
Central low attenuation, n (%) 0.201 0.321
   Present 32 (6.9) 9 (10.0) 23 (6.2) 18 (15.5) 6 (21.4) 12 (13.6)
   Absent 430 (93.1) 81 (90.0) 349 (93.8) 98 (84.5) 22 (78.6) 76 (86.4)
Other pulmonary nodules, n (%) 0.819 0.963
   Present 236 (51.1) 45 (50.0) 191 (51.3) 70 (60.3) 17 (60.7) 53 (60.2)
   Absent 226 (48.9) 45 (50.0) 181 (48.7) 46 (39.7) 11 (39.3) 35 (39.8)
Emphysema, n (%) 0.903 0.985
   Present 79 (17.1) 15 (16.7) 64 (17.2) 25 (21.6) 6 (21.4) 19 (21.6)
   Absent 383 (82.9) 75 (83.3) 308 (2.8) 91 (78.4) 22 (78.6) 69 (78.4)
Pulmonary fibrosis, n (%) 0.406 0.921
   Present 41 (8.9) 10 (11.1) 31 (8.3) 20 (17.2) 5 (17.9) 15 (17.0)
   Absent 421 (91.1) 80 (88.9) 341 (91.7) 96 (82.8) 23 (82.1) 73 (83.0)
Calcification, n (%) 0.912 0.967
   Present 11 (2.4) 2 (2.2) 9 (2.4) 4 (3.4) 1 (3.6) 3 (3.4)
   Absent 451 (97.6) 88 (97.8) 363 (97.6) 112 (96.6) 27 (96.4) 85 (96.6)

Distribution within the lobe: center, the nodule entirely located within the inner two-thirds of the lung; peripheral, a portion of the nodule residing in the outer third of the lung. STAS, spread through air space; LUL, left upper lobe; LLL, left lower lobe; RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe.